DPP4 and type 2 diabetes mellitus: Enhanced serum DPPIV levels and/or activity have been suggested to be correlated with many metabolic diseases, such as type 2 diabetes (T2DM), obesity, cardiovascular disease, and non-alcoholic fatty liver disease (NAFLD) (Röhrborn et al., 2015; Nargis and Chakrabarti, 2018).